Continuous positive airway pressure versus theophylline for apnea in preterm infants

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2001, Pages

  Henderson Smart, David J ^a   Subramaniam, Prema ^b   Davis, Peter G ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WHANGAREI HOSPITAL   (New Zealand)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

THEOPHYLLINE; VASODILATOR AGENT;

APNEA; HUMAN; NEWBORN; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; REVIEW;

APNEA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; POSITIVE-PRESSURE RESPIRATION; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 84921537602     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001072     Document Type: Review

References (16)

1. Jones RAK. The management of recurrent apnoea in the preterm infant (MD thesis). London: University of London, 1981.
2. Jones RAK. Apnoea of prematurity. 1. A controlled trial of theophylline and face mask continuous positive airways pressure. Archives of Disease in Childhood 1982;57:761-5.
3. American Academy of Pediatrics. Policy statement. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003;111:914-17.
4. Allen LP, Blake AM, Durbin GM, Ingram D, Reynolds EOR, Wimberley PD. Continuous positive airway pressure and mechanical ventilation by face mask in newborn infants. British Medical Journal 1975;iv:137-9.
5. Davis PG, Henderson-Smart DJ. Prophylactic post-extubation nasal CPAP in preterm infants. Cochrane Database of Systematic Reviews 2005, Issue 1.
6. Henderson-Smart DJ. Recurrent apnoea. In: Yu VYH editor(s). Bailliere's Clinical Paediatrics. Vol. 3. No. 1 Pulmonary Problems in the Perinatal Period and their Sequelae, London: Bailliere Tindall, 1995:203-22.
7. Henderson-Smart DJ, Steer PA. Methylxanthine treatment for apnea in preterm infants. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD000140]
8. Henderson-Smart DJ, Steer PA. Doxapram treatment for apnea in preterm infants. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD000074.pub2]
9. Henderson-Smart DJ, Steer PA. Doxapram versus methylxanthine for apnea in preterm infants. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD000075]
10. Kattwinkel J, Nearman HS, Fanaroff AA, Katona PG, Klaus MH. Apnea of prematurity. Comparative therapeutic effects of cutaneous stimulation and nasal continuous positive airway pressure. Journal of Pediatrics 1975;86:588-92.
11. Miller MJ, Carlo WA, Martin RJ. Continuous positive pressure selectively reduces obstructive apnea in preterm infants. Journal of Pediatrics 1985;106:91-4.
12. Samuels MP, Southall DP. Recurrent Apnea. In: Sinclair JC, Bracken MB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992:385-97.
13. Speidel BD, Dunn PM. Use of nasal continuous positive airways pressure to treat severe recurrent apnoea in very preterm infants. Lancet 1976;ii:658-60.
14. Steer PA, Henderson-Smart DJ. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD000273]
15. Henderson-Smart DJ, Subramaniam P, Davis PG. Continuous positive airway pressure versus theophylline for apnea in preterm infants. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD001072]
16. Henderson-Smart DJ, Subramaniam P, Davis PG. Continuous positive airway pressure versus theophylline for apnea in preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD001072]